MISSD launches akathisia awareness ads in Australia

MISSD has launched its first television campaign in Australia to raise awareness of akathisia, a medication-induced disorder linked to severe distress, self-harm and suicide. The effort arrives ahead of Prescribed Harm Awareness Day and expands the foundation’s push to educate patients, families and clinicians about drug-induced harm.

Why it matters: - Akathisia can trigger intense restlessness and agitation that may be mistaken for worsening mental illness. - Better recognition can change prescribing decisions, improve patient safety and reduce avoidable harm. - The campaign lands in Australia as about 5 million people there receive mental health-related prescriptions, raising questions about whether some long-term distress is being treated with medication when other supports may be needed.

What happened: - MISSD, the Medication-Induced Suicide Prevention and Education Foundation in Memory of Stewart Dolin, launched akathisia awareness ads in Australia. - The rollout includes television commercials and billboards. - MISSD said the campaign is its first television advertising effort. - The launch comes ahead of Prescribed Harm Awareness Day, which is observed tomorrow and was founded by Stephen’s Voice, an Ireland-based charity.

The details: - Akathisia is associated with inner restlessness, severe agitation, pacing, rocking, shifting and unusual changes in thoughts, feelings and behavior. - The disorder has been linked to commonly prescribed medications used for nausea, infection, asthma, depression, high blood pressure, anxiety and acne. - When clinically appropriate, management may include reducing, stopping or changing the causative medication under the supervision of a healthcare professional familiar with akathisia. - MISSD says its awareness work also includes a podcast and two free online akathisia courses. - MISSD recently released two new episodes of its Akathisia Stories podcast. - One episode features founder Wendy Dolin and MISSD director Jenna Sachman discussing the foundation’s growth over 16 years. - Another episode features Katinka Blackford Newman, author of The Pill That Steals Lives and founder of Antidepressant Risks, a UK nonprofit focused on antidepressant risks. - Antidepressant Risks and A Disorder 4 Everyone will host a Stolen Lives London talk followed by a picnic. - Prescribed Harm Awareness Day picnics have also been organized in Australia, France, Canada, the Netherlands and the United States.

Between the lines: - The campaign is part public health education, part challenge to how medication-related distress is identified and treated. - MISSD is trying to move akathisia from a niche clinical term into a broader safety issue for patients, prescribers and families. - The timing around Prescribed Harm Awareness Day reinforces the message that some harms stem from treatment itself, not only from the underlying condition. - Wendy Dolin said greater awareness of iatrogenic harm can improve healthcare outcomes, enhance patient safety and better support people who experience adverse drug effects.

What's next: - MISSD is likely to keep building awareness through media, educational materials and podcast programming. - The Australian ad push could set up more international outreach if the campaign gains traction. - Prescribed Harm Awareness Day events in multiple countries may further widen attention to medication-induced harm.

The bottom line: - MISSD is using its first TV campaign to push akathisia into the public spotlight and argue that medication-induced harm deserves earlier recognition and faster action.